Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group
about
Emerging biological therapies to treat acute lymphoblastic leukemia.Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview.Expression of novel fusion antiviral proteins ricin a chain-pokeweed antiviral proteins (RTA-PAPs) in Escherichia coli and their inhibition of protein synthesis and of hepatitis B virus in vitro
P2860
Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Feasibility Study of a Novel E ...... the Children's Oncology Group
@ast
Feasibility Study of a Novel E ...... the Children's Oncology Group
@en
type
label
Feasibility Study of a Novel E ...... the Children's Oncology Group
@ast
Feasibility Study of a Novel E ...... the Children's Oncology Group
@en
prefLabel
Feasibility Study of a Novel E ...... the Children's Oncology Group
@ast
Feasibility Study of a Novel E ...... the Children's Oncology Group
@en
P2093
P2860
P50
P1476
Feasibility Study of a Novel E ...... the Children's Oncology Group
@en
P2093
Doojduen Villaluna
Gregory Reaman
Holly J Meany
Judith K Sato
Julie R Park
Mark Krailo
Raymond Hutchinson
Robert J Wells
William G Woods
Zhengjia Chen
P2860
P304
P356
10.1097/CJI.0000000000000088
P577
2015-09-01T00:00:00Z